Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 517 of the 517 references it cites were found in a registry or an index.

The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited

Open access

Published version of a preprint

Abstract

Tumorigenesis is a complex and dynamic process involving cell-cell and cell-extracellular matrix (ECM) interactions that allow tumor cell growth, drug resistance and metastasis. This review provides an updated summary of the role played by the tumor microenvironment (TME) components and hypoxia in tumorigenesis, and highlight various ways through which tumor cells reprogram normal cells into phenotypes that are pro-tumorigenic, including cancer associated- fibroblasts, -macrophages and -endothelial cells. Tumor cells secrete numerous factors leading to the transformation of a previously anti-tumorigenic environment into a pro-tumorigenic environment. Once formed, solid tumors continue to interact with various stromal cells, including local and infiltrating fibroblasts, macrophages, mesenchymal stem cells, endothelial cells, pericytes, and secreted factors and the ECM within the tumor microenvironment (TME). The TME is key to tumorigenesis, drug response and treatment outcome. Importantly, stromal cells and secreted factors can initially be anti-tumorigenic, but over time promote tumorigenesis and induce therapy resistance. To counter hypoxia, increased angiogenesis leads to the formation of new vascular networks in order to actively promote and sustain tumor growth via the supply of oxygen and nutrients, whilst removing metabolic waste. Angiogenic vascular network formation aid in tumor cell metastatic dissemination. Successful tumor treatment and novel drug development require the identification and therapeutic targeting of pro-tumorigenic components of the TME including cancer-associated- fibroblasts (CAFs) and -macrophages (CAMs), hypoxia, blocking ECM-receptor interactions, in addition to the targeting of tumor cells. The reprogramming of stromal cells and the immune response to be anti-tumorigenic is key to therapeutic success. Lastly, this review highlights potential TME- and hypoxia-centered therapies under investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers15020376

Cites

517 of 517 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Selection of manuscripts used in the production of this review manuscript.
Figure 1 Selection of manuscripts used in the production of this review manuscript.CC BY · PubMed Central
Figure 2 The tumor microenvironment components and their contribution during tumorigenesis.
Figure 2 The tumor microenvironment components and their contribution during tumorigenesis.CC BY · PubMed Central
Figure 3 Normal fibroblasts are initially anti-tumorigenic within the TME but over time become activated into CAFs and contribute to tumorigenesis through increased synthesis of factors and the ECM.
Figure 3 Normal fibroblasts are initially anti-tumorigenic within the TME but over time become activated into CAFs and contribute to tumorigenesis through increased synthesis of factors and the ECM.CC BY · PubMed Central
Figure 4 Cancer associated fibroblasts are diverse in origin. The origin of CAFs range from tissue resident fibroblasts, pericytes, endothelial cells to mesenchymal stem cells.
Figure 4 Cancer associated fibroblasts are diverse in origin. The origin of CAFs range from tissue resident fibroblasts, pericytes, endothelial cells to mesenchymal stem cells.CC BY · PubMed Central
Figure 5 Components of the ECM include glycoproteins, collagens, proteoglycans, and polysaccharides. Collagens and glycoproteins are ligand for integrins and play key roles in tumor cell signaling necessary for survival.
Figure 5 Components of the ECM include glycoproteins, collagens, proteoglycans, and polysaccharides. Collagens and glycoproteins are ligand for integrins and play key roles in tumor cell signaling necessary for survival.CC BY · PubMed Central
Figure 6 The vascular networks are important during tumorigenesis. Supply of oxygen and removal of carbon dioxide and other metabolic waste products is achieved by the blood vessels. Leaky blood vessels also allow tumor cells to migrate to other tissues and organs.
Figure 6 The vascular networks are important during tumorigenesis. Supply of oxygen and removal of carbon dioxide and other metabolic waste products is achieved by the blood vessels. Leaky blood vessels also allow tumor cells to migrate to other tissues and organs.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 509 references

Cited by

See all 160

Metadata

Authors
Dzobo, K., Senthebane, D. A., & Dandara, C.
Affiliations
  • South African Medical Research Council (ZA)
  • University of Cape Town (ZA)
Corresponding author
Dzobo, Kevin
Venue
Cancers
Publisher
MDPI AG
Published
2023-01-06
Volume
15
Issue
2
Pages
376
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4313640373
Cited by
146
References
509
Citations by year
2026: 33 · 2025: 26 · 2024: 51 · 2023: 36
FWCI
4.73
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • Preprints.org (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Open University of Cape Town (University of Cape Town) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
tumor microenvironment, carcinogenesis, treatment resistance, hypoxia, cancer-associated fibroblasts, cancer-associated macrophages, tumor endothelial cells, tumor stroma, extracellular matrix, angiogenesis, metastasis, ECM-receptor interaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited. https://app.cochat.ai/papers/10.3390/cancers15020376
The paper
Dzobo, K., Senthebane, D. A., & Dandara, C. (2023). The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited. Cancers. https://doi.org/10.3390/cancers15020376

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.